Clinical Study Current medical science 2023

Hyperbaric Oxygen Treatment for Long COVID: From Molecular Mechanism to Clinical Practice.

Pan JQ, Tian ZM, Xue LB — Current medical science, 2023

View Original on PubMed PMID 37924387

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reviewed the molecular mechanisms and clinical trial evidence for hyperbaric oxygen therapy (HBOT) in treating Long COVID.

What They Found

The review found that hyperbaric oxygen therapy (HBOT) improves microcirculation, inhibits inflammation and autoimmune responses, and promotes neurological repair. Clinical trials suggest HBOT helps improve symptom severity, reduce symptom duration, and enhance quality of life for Long COVID patients.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

The abstract does not provide specific quantitative data from the reviewed clinical trials, limiting the ability to assess the precise magnitude of HBOT's effects.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type	Clinical Study
Category	Neurological
Source	Pubmed
PubMed ID	37924387
Year Published	2023
Journal	Current medical science
MeSH Terms	Humans; Hyperbaric Oxygenation; Oxygen; Post-Acute COVID-19 Syndrome; Quality of Life; Epstein-Barr Virus Infections; COVID-19; Herpesvirus 4, Human

Related Research

PLoS ONE | 2013 RCT

Hyperbaric oxygen induces late neuroplasticity in post stroke patients--randomized, prospective trial.

Efrati S, Fishlev G, Bechor Y, et al.

J Neurotrauma | 2018 Systematic Review

Hyperbaric oxygen therapy in the treatment of acute severe traumatic brain injury: a systematic review

Daly S, Thorpe M, Rockswold S, et al.

J Neurotrauma | 2012 Pilot Study

A phase I study of low-pressure hyperbaric oxygen therapy for blast-induced post-concussion syndrome and PTSD

Harch PG, Andrews SR, Fogarty EF, et al.

Scientific Reports | 2022 RCT

Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial.

Hadanny A, Zilberman-Itskovich S, Catalogna M, et al.

PLoS ONE | 2013 RCT

Hyperbaric oxygen therapy can improve post concussion syndrome years after mild traumatic brain injury — randomized prospective trial

Boussi-Gross R, Golan H, Fishlev G, et al.

See all Neurological research

View on PubMed Back to Research Library

Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology